210 related articles for article (PubMed ID: 32846403)
1. Understanding metabolomic characteristics of pancreatic ductal adenocarcinoma by HR-MAS NMR detection of pancreatic tissues.
Wang S; Wen S; Guo P; Liu H; Feng J; Huang H
J Pharm Biomed Anal; 2020 Oct; 190():113546. PubMed ID: 32846403
[TBL] [Abstract][Full Text] [Related]
2. Metabonomic changes from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma in tissues from rats.
Wen S; Li Z; Feng J; Bai J; Lin X; Huang H
Cancer Sci; 2016 Jun; 107(6):836-45. PubMed ID: 27019331
[TBL] [Abstract][Full Text] [Related]
3. HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer.
Wang AS; Lodi A; Rivera LB; Izquierdo-Garcia JL; Firpo MA; Mulvihill SJ; Tempero MA; Bergers G; Ronen SM
NMR Biomed; 2014 Nov; 27(11):1361-70. PubMed ID: 25199993
[TBL] [Abstract][Full Text] [Related]
4. A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma.
Sahni S; Pandya AR; Hadden WJ; Nahm CB; Maloney S; Cook V; Toft JA; Wilkinson-White L; Gill AJ; Samra JS; Dona A; Mittal A
Int J Cancer; 2021 Mar; 148(6):1508-1518. PubMed ID: 33128797
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic ductal adenocarcinoma is associated with a distinct urinary metabolomic signature.
Davis VW; Schiller DE; Eurich D; Bathe OF; Sawyer MB
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S415-23. PubMed ID: 23096698
[TBL] [Abstract][Full Text] [Related]
6. Metabolic profiling of colorectal cancer organoids: A comparison between high-resolution magic angle spinning magnetic resonance spectroscopy and solution nuclear magnetic resonance spectroscopy of polar extracts.
van der Kemp WJM; Grinde MT; Malvik JO; van Laarhoven HWM; Prompers JJ; Klomp DWJ; Burgering B; Bathen TF; Moestue SA
NMR Biomed; 2023 Apr; 36(4):e4882. PubMed ID: 36451530
[TBL] [Abstract][Full Text] [Related]
7. The Role of High-Resolution Magic Angle Spinning 1H Nuclear Magnetic Resonance Spectroscopy for Predicting the Invasive Component in Patients with Ductal Carcinoma In Situ Diagnosed on Preoperative Biopsy.
Chae EY; Shin HJ; Kim S; Baek HM; Yoon D; Kim S; Shim YE; Kim HH; Cha JH; Choi WJ; Lee JH; Shin JH; Lee HJ; Gong G
PLoS One; 2016; 11(8):e0161038. PubMed ID: 27560937
[TBL] [Abstract][Full Text] [Related]
8. Metabonomic alterations from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma facilitate the identification of biomarkers in serum for early diagnosis of pancreatic cancer.
Lin X; Zhan B; Wen S; Li Z; Huang H; Feng J
Mol Biosyst; 2016 Aug; 12(9):2883-92. PubMed ID: 27400832
[TBL] [Abstract][Full Text] [Related]
9. Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer.
Dutta P; Perez MR; Lee J; Kang Y; Pratt M; Salzillo TC; Weygand J; Zacharias NM; Gammon ST; Koay EJ; Kim M; McAllister F; Sen S; Maitra A; Piwnica-Worms D; Fleming JB; Bhattacharya PK
J Proteome Res; 2019 Jul; 18(7):2826-2834. PubMed ID: 31120258
[TBL] [Abstract][Full Text] [Related]
10. Grading of endometrial cancer using
Skorupa A; Poński M; Ciszek M; Cichoń B; Klimek M; Witek A; Pakuło S; Boguszewicz Ł; Sokół M
Sci Rep; 2021 Sep; 11(1):18160. PubMed ID: 34518615
[TBL] [Abstract][Full Text] [Related]
11. Discrimination of metabolic profiles of pancreatic cancer from chronic pancreatitis by high-resolution magic angle spinning 1H nuclear magnetic resonance and principal components analysis.
Fang F; He X; Deng H; Chen Q; Lu J; Spraul M; Yu Y
Cancer Sci; 2007 Nov; 98(11):1678-82. PubMed ID: 17727683
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic and transcriptomic profiling of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas.
Yabushita S; Fukamachi K; Tanaka H; Fukuda T; Sumida K; Deguchi Y; Mikata K; Nishioka K; Kawamura S; Uwagawa S; Suzui M; Alexander DB; Tsuda H
Carcinogenesis; 2013 Jun; 34(6):1251-9. PubMed ID: 23393225
[TBL] [Abstract][Full Text] [Related]
13. Urine metabolic signature of pancreatic ductal adenocarcinoma by (1)h nuclear magnetic resonance: identification, mapping, and evolution.
Napoli C; Sperandio N; Lawlor RT; Scarpa A; Molinari H; Assfalg M
J Proteome Res; 2012 Feb; 11(2):1274-83. PubMed ID: 22066465
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic profiles of intact tissues reflect clinically relevant prostate cancer subtypes.
Dudka I; Lundquist K; Wikström P; Bergh A; Gröbner G
J Transl Med; 2023 Nov; 21(1):860. PubMed ID: 38012666
[TBL] [Abstract][Full Text] [Related]
15. High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance Spectroscopy for the Metabolic Assessment of Acute Rejection After Cardiac Transplantation in Rats.
Lee CW; Lee JS; Woo CW; Kim S
Transplant Proc; 2017 Oct; 49(8):1935-1941. PubMed ID: 28923651
[TBL] [Abstract][Full Text] [Related]
16. Quantitative NMR-Based Metabolomics on Tissue Biomarkers and Its Translation into In Vivo Magnetic Resonance Spectroscopy.
Serkova NJ; Davis DM; Steiner J; Agarwal R
Methods Mol Biol; 2019; 1978():369-387. PubMed ID: 31119675
[TBL] [Abstract][Full Text] [Related]
17. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.
Sitter B; Lundgren S; Bathen TF; Halgunset J; Fjosne HE; Gribbestad IS
NMR Biomed; 2006 Feb; 19(1):30-40. PubMed ID: 16229059
[TBL] [Abstract][Full Text] [Related]
18. Merging transcriptomics and metabolomics--advances in breast cancer profiling.
Borgan E; Sitter B; Lingjærde OC; Johnsen H; Lundgren S; Bathen TF; Sørlie T; Børresen-Dale AL; Gribbestad IS
BMC Cancer; 2010 Nov; 10():628. PubMed ID: 21080935
[TBL] [Abstract][Full Text] [Related]
19. Metabolic responses to the occurrence and chemotherapy of pancreatic cancer: biomarker identification and prognosis prediction.
Teng T; Shi H; Fan Y; Guo P; Zhang J; Qiu X; Feng J; Huang H
Sci Rep; 2024 Mar; 14(1):6938. PubMed ID: 38521793
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
